Conference Coverage

FDA panel calls for changes to breast implant rupture screening

Publish date: March 27, 2019

 

AT AN FDA ADVISORY PANEL MEETING

Pages

Recommended Reading

Riboflavin helps visualize urine flow during cystoscopy
MDedge ObGyn
Conservatism spreads in prostate cancer
MDedge ObGyn
FDA panel tackles mesh for anterior repair of POP
MDedge ObGyn
Minilaparotomy: Minimally invasive approach to abdominal myomectomy
MDedge ObGyn
Von Willebrand disease screening is low prior to hysterectomy
MDedge ObGyn
Can prophylactic salpingectomies be achieved with the vaginal approach?
MDedge ObGyn
Opportunistic salpingectomy appears to reduce risk of ovarian cancer
MDedge ObGyn
Knotless, absorbable sutures best staples for postcesarean skin closure
MDedge ObGyn
Postcesarean pain relief better on nonopioid regimen
MDedge ObGyn
FDA panel leans toward more robust breast implant surveillance
MDedge ObGyn